Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Ludwig

Showing results (1-10 of 231) with videos related to

Pageof 24
Sort By:
Biological Chemistry|August 10, 2011
Disruption of virus-host cell interactions and cell signaling pathways as an anti-viral approach against influenza virus infectionsStephan Ludwig
Trends in Microbiology|April 1, 2014
Will omics help to cure the flu?Stephan Ludwig
The Journal of Antimicrobial Chemotherapy|May 8, 2009
Targeting cell signalling pathways to fight the flu: towards a paradigm change in anti-influenza therapyStephan Ludwig
Biological Chemistry|October 17, 2008
Highlight - viruses and signalingStephan Ludwig
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 8, 2020
Corrigendum to "Contiguous pattern spreading in patients with Hodgkin's disease" [Radiother. Oncol. 47 (1998) 7-16]Stephan Ludwig Roth
Cellular Microbiology|March 18, 2009
A new player in a deadly game: influenza viruses and the PI3K/Akt signalling pathwayChristina Ehrhardt, Stephan Ludwig
Antiviral Research|February 9, 2025
Host-targeted antivirals against SARS-CoV-2 in clinical development - Prospect or disappointment?André Schreiber, Stephan Ludwig
Biological Chemistry|August 21, 2008
Influenza viruses and the NF-kappaB signaling pathway - towards a novel concept of antiviral therapyStephan Ludwig, Oliver Planz
The FEBS Journal|January 26, 2017
Targeting a metabolic pathway to fight the fluYvonne Boergeling, Stephan Ludwig
Cell Host & Microbe|May 21, 2009
Influenza A virus TRIMs the type I interferon responseStephan Ludwig, Thorsten Wolff
Pageof 24

Showing results (1-10 of 231) with videos related to

Sort By:
Pageof 24
Biological Chemistry|August 10, 2011
Disruption of virus-host cell interactions and cell signaling pathways as an anti-viral approach against influenza virus infectionsStephan Ludwig
Trends in Microbiology|April 1, 2014
Will omics help to cure the flu?Stephan Ludwig
The Journal of Antimicrobial Chemotherapy|May 8, 2009
Targeting cell signalling pathways to fight the flu: towards a paradigm change in anti-influenza therapyStephan Ludwig
Biological Chemistry|October 17, 2008
Highlight - viruses and signalingStephan Ludwig
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 8, 2020
Corrigendum to "Contiguous pattern spreading in patients with Hodgkin's disease" [Radiother. Oncol. 47 (1998) 7-16]Stephan Ludwig Roth
Cellular Microbiology|March 18, 2009
A new player in a deadly game: influenza viruses and the PI3K/Akt signalling pathwayChristina Ehrhardt, Stephan Ludwig
Antiviral Research|February 9, 2025
Host-targeted antivirals against SARS-CoV-2 in clinical development - Prospect or disappointment?André Schreiber, Stephan Ludwig
Biological Chemistry|August 21, 2008
Influenza viruses and the NF-kappaB signaling pathway - towards a novel concept of antiviral therapyStephan Ludwig, Oliver Planz
The FEBS Journal|January 26, 2017
Targeting a metabolic pathway to fight the fluYvonne Boergeling, Stephan Ludwig
Cell Host & Microbe|May 21, 2009
Influenza A virus TRIMs the type I interferon responseStephan Ludwig, Thorsten Wolff
Pageof 24